9 research outputs found
Can an increase in autoantibody levels predict arthritis in arthralgia patients?
No full textRetrospective studies have shown that anti-citrullinated protein antibodies (ACPA) and IgM rheumatoid factor (RF) often precede symptom onset of rheumatoid arthritis (RA) by many years, and the closer the individual comes to clinical arthritis the more positivity for either one or the combination is found, together with increasing levels(1, 2). To our knowledge no individual prediction models using autoantibody levels over time have been developed yet. In a prospective study we investigated whether change of ACPA and RF levels over time within individuals improves prediction of future arthritis in seropositive arthralgia patients
Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis
No full textEvaluation of serum14-3-3η protein and Sema3A levels in rheumatoid arthritis: diagnostic and prognostic value
No full textPreventing progression from arthralgia to arthritis: targeting the right patients
No full textPathophysiology and treatment of rheumatic disease
Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren’s syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis
No full text
